Trademark: 90641216
Status Date
Monday, September 25, 2023
Filing Date
Tuesday, April 13, 2021
Published for Opposition
Tuesday, December 28, 2021
Abandoned Date
Monday, September 25, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Sep 25, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 25, 2023
Abandonment - No Use Statement Filed
Jan 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 26, 2023
Sou Extension 2 Granted
Jan 26, 2023
Sou Extension 2 Filed
Jan 26, 2023
Sou Teas Extension Received
Aug 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 8, 2022
Sou Extension 1 Granted
Aug 8, 2022
Sou Extension 1 Filed
Aug 8, 2022
Sou Teas Extension Received
Feb 22, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 28, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 28, 2021
Published For Opposition
Dec 8, 2021
Notification Of Notice Of Publication E-Mailed
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 24, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 23, 2021
Approved For Pub - Principal Register
Nov 23, 2021
Assigned To Examiner
Jul 20, 2021
New Application Office Supplied Data Entered
Apr 16, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
